Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reproxalap in Sjögren-Larsson Syndrome
NCT03445650Phase 3Completed
- Sponsor
- Aldeyra Therapeutics
- Start
- Jul 2018
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of reproxalap in Sjögren-Larsson syndrome (SLS), sponsored by Aldeyra Therapeutics. Started Jul 2018; status: completed.
02
Drugs
reproxalap
03
Conditions
Sjögren-Larsson syndrome (SLS)
Beyond the preview
Go deeper on NCT03445650.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03445650.